Arcadia Biosciences (RKDA) to Release Earnings on Thursday

Arcadia Biosciences (NASDAQ:RKDA) will announce its earnings results after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($2.52) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings results on Thursday, March 28th. The basic materials company reported ($2.48) EPS for the quarter, topping the consensus estimate of ($2.68) by $0.20. Arcadia Biosciences had a negative net margin of 246.80% and a negative return on equity of 81.56%. The firm had revenue of $1.17 million for the quarter, compared to analyst estimates of $1.80 million.

Arcadia Biosciences Price Performance

NASDAQ RKDA opened at $2.01 on Wednesday. The company has a fifty day moving average of $2.24 and a two-hundred day moving average of $2.67. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $7.30. The company has a market capitalization of $2.73 million, a PE ratio of -0.14 and a beta of 0.62.

Analysts Set New Price Targets

RKDA has been the topic of a number of research reports. HC Wainwright restated a “buy” rating and set a $10.00 price target on shares of Arcadia Biosciences in a research note on Friday, April 5th. StockNews.com began coverage on shares of Arcadia Biosciences in a report on Tuesday. They issued a “sell” rating on the stock.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.